Measurement of blood flow rate (Qa) is used to monitor arteriovenous fistulas and grafts that are used for hemodialysis blood access. Most Qa measurements use indicator dilution techniques to measure the recirculation that is induced by the reversal of hemodialysis blood lines. R plus the dialysis circuit flow (Qb) allows the calculation of Qa. The principle of needle reversal also can be used with a dialysate urea monitor (e.g., DQM 200 [Gambro]) without injection of diluent; the effect of the reversal on urea concentration is observed. Access blood water flow rate (Qaw) in relation to the effective clearance (K) is found from the urea concentrations in the dialysate with needles in the normal (Cn) and reverse (Cr) positions: K/Qaw = (Cn - Cr)/Cr. Qa is calculated by adjusting Qaw for hematocrit and protein. For testing of this theoretical relationship, 20 patients who were dialyzed on Integra (Hospal) and Centrysystem 3 (Cobe) machines that were fitted with DQM 200 were studied. During each treatment, lines were reversed and Qa was measured by ultrasound velocity dilution (Transonic HD01 monitor); at the same time, Cn and Cr were measured by DQM 200 and K was calculated. K1 was determined from a predialysis blood urea concentration (Cb), initial dialysate urea concentration (Cd), dialysate flow rate (Qd), and the relationship K x Cb = Qd x Cd (K1). K was determined separately from a conductivity step method using Diascan (Hospal) attached to Integra machines only (K2). With the use of K1, 127 comparisons were made; a correlation existed (r = 0.916), although Bland-Altman analysis showed that the dialysate urea method gave a mean value 5.3% +/- 15.3 (+/-SD) higher than that of Transonic (P < 0.001). With the use of K2, there also was a correlation of (r = 0.944; n = 63), and Bland-Altman testing showed an NS difference of +3.5% between the dialysate urea and Transonic methods. Qa can be estimated from on-line dialysate urea measurements that are taken before and after line reversal together with knowledge of K.

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.00810306DOI Listing

Publication Analysis

Top Keywords

dialysate urea
24
hemodialysis blood
12
flow rate
12
dqm 200
12
urea concentration
12
urea
10
blood access
8
dialysate
8
on-line dialysate
8
urea measurements
8

Similar Publications

Background: Chronic kidney disease (CKD) patients have an increased risk of cardiovascular disease (CVD), necessitating effective risk assessment methods. This study evaluates the calcium-phosphorus product (Ca × P) to estimated glomerular filtration rate (Ca × P/eGFR) ratio as a potential biomarker for predicting CV risk in pre-dialysis CKD patients.

Methods: Eighty-four CKD patients in stages G1-G4, according to the KDIGO criteria, were classified into CVD ( = 43) and non-CVD ( = 41) groups.

View Article and Find Full Text PDF

Background: In patients with chronic kidney disease (CKD), trimethylamine n-oxide (TMAO) accumulation exacerbates inflammation and contributes to oxidative stress. These complications are putatively linked to the development of cardiovascular diseases. Despite the known associations, the variation in TMAO plasma levels across different CKD stages and dialysis modalities remains underexplored.

View Article and Find Full Text PDF

Introduction: Phosphate (P) binders are among the most common medications prescribed to control P levels in patients with chronic kidney disease on dialysis. There is still a paucity of data on adherence to P binders with no comparison between dialysis modalities.

Methods: We accessed factors associated with P binder adherence among patients on dialysis in an academic hospital.

View Article and Find Full Text PDF

Elderly patients undergoing maintenance hemodialysis (MHD) face a heightened risk of cognitive frailty (CF), which significantly compromises quality of life. Early identification of at-risk individuals and timely intervention are essential. Nevertheless, current CF risk prediction models fall short in accuracy to adequately fulfill clinical requirements.

View Article and Find Full Text PDF

Background: Oral nutritional supplements (ONS) are commonly prescribed to provide protein and energy to hemodialysis (HD) patients. There is a debate about the appropriate timing to administer ONS. We aimed to study the effect of different timings of ONS on variable outcomes in HD patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!